Skip to Content
You are currently on the new version of our website. Access the old version .

4,819 Results Found

  • Article
  • Open Access
1 Citations
2,123 Views
12 Pages

Evaluation of CK8/18 and CK19 Expression as Adjunct Immunohistochemical Markers in Non-Keratinizing Nasopharyngeal Carcinoma

  • Ummul Afila Omar,
  • Suria Hayati Binti Md Pauzi,
  • Mohd Razif Bin Mohamad Yunus,
  • Rosnah Sutan and ,
  • Nur Maya Sabrina binti Tizen Laim,
  • Muaatamarulain bin Mustangin and
  • Reena Rahayu Md Zin
  • + 2 authors+ 0 author

10 September 2025

Background: Nasopharyngeal carcinoma (NPC), particularly the non-keratinizing subtype (NK-NPC), is prevalent in Southeast Asia and often presents diagnostic challenges due to overlapping histological features with benign nasopharyngeal lesions. While...

(This article belongs to the Special Issue Challenges Related to the Oral Cavity, Head and Neck: From Diagnosis to Therapy)
  • Article
  • Open Access
22 Citations
9,818 Views
11 Pages

Clinical Significance of CK19 Negative Breast Cancer

  • Mamiko Fujisue,
  • Reiki Nishimura,
  • Yasuhiro Okumura,
  • Rumiko Tashima and ,
  • Yasuyuki Nishiyama,
  • Tomofumi Osako,
  • Yasuo Toyozumi and
  • Nobuyuki Arima
  • + 3 authors+ 0 author

21 December 2012

Analysis of sentinel lymph nodes (SLNs) by means of One-Step Nucleic Acid Amplification (OSNA) is gaining widespread use as a quick and accurate method. This assay detects the expression level of cytokeratin 19 (CK19) which is present in some but not...

  • Technical Note
  • Open Access
18 Citations
8,285 Views
12 Pages

Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers

  • Bram Lesaffer,
  • Elisabeth Verboven,
  • Leen Van Huffel,
  • Iván M. Moya and ,
  • Leo A. van Grunsven,
  • Isabelle A. Leclercq,
  • Frédéric P. Lemaigre and
  • Georg Halder
  • + 3 authors+ 0 author

25 April 2019

Inducible cyclization recombinase (Cre) transgenic mouse strains are powerful tools for cell lineage tracing and tissue-specific knockout experiments. However, low efficiency or leaky expression can be important pitfalls. Here, we compared the effici...

(This article belongs to the Special Issue Hepatic Stem Cells in Liver and Biliary Regeneration)
  • Review
  • Open Access
14 Citations
3,220 Views
16 Pages

Protein Kinase CK2α’, More than a Backup of CK2α

  • Mathias Montenarh and
  • Claudia Götz

14 December 2023

The serine/threonine protein kinase CK2 is implicated in the regulation of fundamental processes in eukaryotic cells. CK2 consists of two catalytic α or α’ isoforms and two regulatory CK2β subunits. These three proteins exist i...

  • Article
  • Open Access
1 Citations
2,114 Views
22 Pages

Crystallographic Fragment Screening with CK2α’, an Isoform of Human Protein Kinase CK2 Catalytic Subunit, and Its Use to Obtain a CK2α’/Heparin Complex Structure

  • Christian Werner,
  • Tatjana Barthel,
  • Hugo Harasimowicz,
  • Christelle Marminon and ,
  • Manfred S. Weiss,
  • Marc Le Borgne and
  • Karsten Niefind
  • + 2 authors+ 0 author

CK2α and CK2α’, two paralogous members of the human kinome, are catalytic subunits of protein kinase CK2. Together with the regulatory subunit CK2β, they form heterotetrameric holoenzymes. CK2 is the subject of efforts to devel...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research—2nd Edition)
  • Article
  • Open Access
3 Citations
8,947 Views
12 Pages

Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer

  • Alice Court,
  • David Laville,
  • Sami Dagher,
  • Vincent Grosjean and ,
  • Pierre Dal-Col,
  • Violaine Yvorel,
  • François Casteillo,
  • Sophie Bayle-Bleuez,
  • Jean-Michel Vergnon and
  • Fabien Forest
  • + 5 authors+ 0 author

Anti-CK7 and anti-CK20 immunohistochemistry is sometimes used to establish a diagnosis of primary lung cancer. We performed a retrospective study on the value of anti-CK7 and anti-CK20 immunohistochemistry in 359 biopsies of patients with suspected l...

(This article belongs to the Special Issue Immunohistochemistry in Cancer Diagnoses and Treatments)
  • Review
  • Open Access
29 Citations
6,671 Views
17 Pages

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2

  • Zaira Spinello,
  • Anna Fregnani,
  • Laura Quotti Tubi,
  • Livio Trentin and ,
  • Francesco Piazza and
  • Sabrina Manni
  • + 1 author+ 0 author

Disturbance of protein kinase activity may result in dramatic consequences that often lead to cancer development and progression. In tumors of blood origin, both tyrosine kinases and serine/threonine kinases are altered by different types of mutation...

(This article belongs to the Special Issue Protein Kinases: Function, Substrates, and Implication in Diseases)
  • Article
  • Open Access
18 Citations
7,329 Views
19 Pages

Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α′

  • Jennifer Hochscherf,
  • Dirk Lindenblatt,
  • Benedict Witulski,
  • Robin Birus and ,
  • Dagmar Aichele,
  • Christelle Marminon,
  • Zouhair Bouaziz,
  • Marc Le Borgne,
  • Joachim Jose and
  • Karsten Niefind
  • + 5 authors+ 0 author

13 December 2017

Protein kinase CK2, a member of the eukaryotic protein kinase superfamily, is associated with cancer and other human pathologies and thus an attractive drug target. The indeno[1,2-b]indole scaffold is a novel lead structure to develop ATP-competitive...

  • Communication
  • Open Access
1 Citations
1,840 Views
13 Pages

Comparative Efficacy of CK2 Inhibitors CX-4945 and SGC-CK2-2 on CK2 Signaling

  • Francesca Noventa,
  • Rina Venerando,
  • Valentina Bosello Travain and
  • Mauro Salvi

14 October 2025

The pleiotropic kinase CK2 plays a crucial role in numerous cellular processes and is frequently deregulated in human diseases. Specifically, elevated CK2 expression and/or activity have been observed in human cancers, thus rendering its inhibition a...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
10 Citations
4,279 Views
17 Pages

The structural knowledge about protein kinase CK2 is dominated by crystal structures of human CK2α, the catalytic subunit of human CK2, and the product of the CSNK2A1 gene. In contrast, far fewer structures of CK2α′, its paralogous...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research)
  • Review
  • Open Access
78 Citations
9,888 Views
17 Pages

CK2—An Emerging Target for Neurological and Psychiatric Disorders

  • Julia Castello,
  • Andre Ragnauth,
  • Eitan Friedman and
  • Heike Rebholz

Protein kinase CK2 has received a surge of attention in recent years due to the evidence of its overexpression in a variety of solid tumors and multiple myelomas as well as its participation in cell survival pathways. CK2 is also upregulated in the m...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Review
  • Open Access
67 Citations
11,498 Views
19 Pages

Targeting Casein Kinase 1 (CK1) in Hematological Cancers

  • Pavlína Janovská,
  • Emmanuel Normant,
  • Hari Miskin and
  • Vítězslav Bryja

27 November 2020

The casein kinase 1 enzymes (CK1) form a family of serine/threonine kinases with seven CK1 isoforms identified in humans. The most important substrates of CK1 kinases are proteins that act in the regulatory nodes essential for tumorigenesis of hemato...

(This article belongs to the Special Issue Protein Kinases: Function, Substrates, and Implication in Diseases)
  • Article
  • Open Access
7 Citations
2,871 Views
14 Pages

Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma

  • Anne S. Boewe,
  • Silke Wemmert,
  • Philipp Kulas,
  • Bernhard Schick and ,
  • Claudia Götz,
  • Selina Wrublewsky,
  • Mathias Montenarh,
  • Michael D. Menger,
  • Matthias W. Laschke and
  • Emmanuel Ampofo
  • + 5 authors+ 0 author

Juvenile angiofibroma (JA) is a rare fibrovascular neoplasm predominately found within the posterior nasal cavity of adolescent males. JA expresses the proteoglycan nerve–glial antigen (NG)2, which crucially determines the migratory capacity of...

(This article belongs to the Special Issue CK2 Regulation of Cell Death and Targeting in Cancer Treatment)
  • Review
  • Open Access
75 Citations
8,044 Views
18 Pages

CK2 Regulation: Perspectives in 2021

  • Scott E. Roffey and
  • David W. Litchfield

30 September 2021

The protein kinase CK2 (CK2) family encompasses a small number of acidophilic serine/threonine kinases that phosphorylate substrates involved in numerous biological processes including apoptosis, cell proliferation, and the DNA damage response. CK2 h...

(This article belongs to the Special Issue CK2 Regulation of Cell Death and Targeting in Cancer Treatment)
  • Review
  • Open Access
29 Citations
9,878 Views
15 Pages

17 December 2021

Protein Kinase CK2, a constitutively active serine/threonine kinase, fulfills its functions via phosphorylating hundreds of proteins in nearly all cells. It regulates a variety of cellular signaling pathways and contributes to cell survival, prolifer...

(This article belongs to the Special Issue CK2 Regulation of Cell Death and Targeting in Cancer Treatment)
  • Article
  • Open Access
5 Citations
4,879 Views
12 Pages

Expression Patterns of Cytokeratins (CK7, CK20, CK19, CK AE1/AE3) in Atypical Endometrial Hyperplasia Coexisting with Endometrial Cancer

  • Danuta Vasilevska,
  • Vilius Rudaitis,
  • Dorota Lewkowicz,
  • Dominika Širvienė and ,
  • Ugnius Mickys,
  • Marek Semczuk,
  • Bogdan Obrzut and
  • Andrzej Semczuk
  • + 3 authors+ 0 author

21 August 2024

Few studies have evaluated cytokeratin’s (CK) staining patterns in atypical endometrial hyperplasia (AEH) coexisting with early-stage endometrial cancer (EC). We aimed to assess the staining patterns of selected CKs (CK7, CK19, CK20, CK AE1/AE3...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
7 Citations
3,452 Views
12 Pages

SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells

  • Mandy Pack,
  • Claudia Götz,
  • Selina Wrublewsky and
  • Mathias Montenarh

The pyrazolopyrimidine based compound SGC-CK2-1 is a potent and highly specific CK2 inhibitor and a new tool to study the biological functions of protein kinase CK2 irrespective from off-target effects. We used this compound in comparison with the we...

(This article belongs to the Special Issue Protein Kinase Inhibitors for Targeted Anticancer Therapies)
  • Review
  • Open Access
13 Citations
7,240 Views
13 Pages

CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer

  • Janeen H. Trembley,
  • Betsy T. Kren,
  • Md. Joynal Abedin,
  • Rachel I. Vogel and ,
  • Claire M. Cannon,
  • Gretchen M. Unger and
  • Khalil Ahmed
  • + 2 authors+ 0 author

21 February 2017

Protein kinase CK2 demonstrates increased protein expression relative to non-transformed cells in the majority of cancers that have been examined. The elevated levels of CK2 are involved in promoting not only continued proliferation of cancer cells b...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Review
  • Open Access
37 Citations
8,210 Views
63 Pages

CK2 and the Hallmarks of Cancer

  • May-Britt Firnau and
  • Angela Brieger

Cancer is a leading cause of death worldwide. Casein kinase 2 (CK2) is commonly dysregulated in cancer, impacting diverse molecular pathways. CK2 is a highly conserved serine/threonine kinase, constitutively active and ubiquitously expressed in eukar...

(This article belongs to the Special Issue CK2 Regulation of Cell Death and Targeting in Cancer Treatment)
  • Review
  • Open Access
40 Citations
7,845 Views
8 Pages

Exploring the CK2 Paradox: Restless, Dangerous, Dispensable

  • Cinzia Franchin,
  • Christian Borgo,
  • Silvia Zaramella,
  • Luca Cesaro and ,
  • Giorgio Arrigoni,
  • Mauro Salvi and
  • Lorenzo A. Pinna
  • + 2 authors+ 0 author

20 January 2017

The history of protein kinase CK2 is crowded with paradoxes and unanticipated findings. Named after a protein (casein) that is not among its physiological substrates, CK2 remained in search of its targets for more than two decades after its discovery...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Article
  • Open Access
2 Citations
3,845 Views
22 Pages

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation

  • Lea Elsholz,
  • Yasmine Wasser,
  • Patrick Ziegler,
  • Pardes Habib and
  • Aaron Voigt

21 October 2021

The pathological accumulation of α-Synuclein (α-Syn) is the hallmark of neurodegenerative α-synucleinopathies, including Parkinsons’s disease (PD). In contrast to the mostly non-phosphorylated soluble α-Syn, aggregated α-Syn is usually phosphorylated...

(This article belongs to the Special Issue Protein Aggregation and Clearance Mechanisms in Neurodegenerative Diseases)
  • Review
  • Open Access
13 Citations
5,345 Views
18 Pages

CK2 Chemical Probes: Past, Present, and Future

  • Han Wee Ong,
  • David H. Drewry and
  • Alison D. Axtman

Protein kinase casein kinase 2 (CK2/CSNK2) is a pleiotropic kinase involved in many cellular processes and, accordingly, has been identified as a potential target for therapeutic intervention for multiple indications. Significant research effort has...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research)
  • Article
  • Open Access
18 Citations
4,977 Views
26 Pages

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines

  • Congxing Liu,
  • Lydia Witt,
  • Chiara Ianes,
  • Joachim Bischof and ,
  • Marie-Thérèse Bammert,
  • Joana Baier,
  • Stefan Kirschner,
  • Doris Henne-Bruns,
  • Pengfei Xu and
  • Uwe Knippschild
  • + 7 authors+ 2 authors

7 December 2019

Protein kinases of the CK1 family can be involved in numerous physiological and pathophysiological processes. Dysregulated expression and/or activity as well as mutation of CK1 isoforms have previously been linked to tumorigenesis. Among all neoplast...

(This article belongs to the Special Issue Molecular and Translational Research on Colorectal Cancer)
  • Article
  • Open Access
18 Citations
4,986 Views
15 Pages

Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation

  • Madalena C. Pinto,
  • Rainer Schreiber,
  • Joana Lerias,
  • Jiraporn Ousingsawat and ,
  • Aires Duarte,
  • Margarida Amaral and
  • Karl Kunzelmann
  • + 2 authors+ 0 author

5 May 2020

Casein kinase 2 (CK2) is a highly ubiquitous and conserved serine/threonine kinase that forms a tetramer consisting of a catalytic subunit (CK2α) and a regulatory subunit (CK2β). Despite being ubiquitous, CK2 is commonly found at higher ex...

(This article belongs to the Special Issue MiNICAD Special Issue: Ion Channels and Human Diseases)
  • Article
  • Open Access
14 Citations
5,646 Views
27 Pages

Background: Osteoporosis is a degenerative skeletal disease with a limited number of treatment options. CK2.3, a novel peptide, may be a potential therapeutic. It induces osteogenesis and bone formation in vitro and in vivo by acting downstream of BM...

(This article belongs to the Special Issue Osteoporosis: From Molecular Mechanisms to Therapies)
  • Article
  • Open Access
5 Citations
3,605 Views
18 Pages

CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP

  • Aileen Roth,
  • Fabian Gärtner,
  • Katja Mayer,
  • Julian Beyrle and ,
  • Irina König,
  • Uwe Knippschild and
  • Joachim Bischof
  • + 2 authors+ 0 author

Alzheimer’s disease (AD) is the major cause of dementia, and affected individuals suffer from severe cognitive, mental, and functional impairment. Histologically, AD brains are basically characterized by the presence of amyloid plaques and neurofibri...

(This article belongs to the Special Issue Protein Kinases and Their Inhibitors in CNS Diseases)
  • Article
  • Open Access
4 Citations
2,547 Views
14 Pages

Characterization of RAGE and CK2 Expressions in Human Fetal Membranes

  • Karen Coste,
  • Shaam Bruet,
  • Caroline Chollat-Namy,
  • Odile Filhol and ,
  • Claude Cochet,
  • Denis Gallot,
  • Geoffroy Marceau,
  • Loïc Blanchon,
  • Vincent Sapin and
  • Corinne Belville
  • + 5 authors+ 0 author

17 February 2023

At the feto-maternal interface, fetal membranes (FM) play a crucial role throughout pregnancy. FM rupture at term implicates different sterile inflammation mechanisms including pathways activated by the transmembrane glycoprotein receptor for advance...

(This article belongs to the Special Issue Advanced Glycation End Products (AGEs) and Their Receptor RAGE)
  • Article
  • Open Access
3 Citations
2,105 Views
25 Pages

Regulation of Mouse CK2α (Csnk2a1) Promoter Expression In Vitro and in Cell Lines

  • Gregory A. Imbrie,
  • Nicholas G. Wilson,
  • David C. Seldin and
  • Isabel Dominguez

CK2α is a kinase important for essential cellular and biological processes. CK2α is ubiquitously expressed, albeit at different tissue levels, and its transcript levels are dysregulated in disease. However, there is limited knowledge on t...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research)
  • Review
  • Open Access
9 Citations
4,061 Views
18 Pages

Protein Kinase CK2 and Epstein–Barr Virus

  • Mathias Montenarh,
  • Friedrich A. Grässer and
  • Claudia Götz

Protein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis,...

(This article belongs to the Special Issue CK2 Regulation of Cell Death and Targeting in Cancer Treatment)
  • Article
  • Open Access
1,902 Views
16 Pages

CK2α Overexpression in Colorectal Cancer: Evidence for Sex- and Age-Linked Differences

  • Jana Romy Friedrich,
  • Clara Meier,
  • Guido Plotz,
  • Stefan Zeuzem and ,
  • Angela Brieger and
  • Sarah J. Overby
  • + 1 author+ 0 author

30 August 2025

Background/Objectives: Colorectal cancer (CRC) remains a leading cause of cancer-related deaths, with notable sex-specific differences in its incidence, diagnosis, and outcomes. Our previous work identified casein kinase 2 alpha (CK2α) as being...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
1 Citations
1,632 Views
22 Pages

Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma

  • Marzena Lenda-Petrykowska,
  • Violetta Sulżyc-Bielicka,
  • Wojciech Dobrzycki,
  • Krzysztof Safranow and ,
  • Jerzy Świtała,
  • Dorota Kostrzewa-Nowak and
  • Paweł Bielicki
  • + 2 authors+ 0 author

9 October 2025

Background/Objectives: The study aimed to determine whether the expression of CK5/6 and GATA3 is altered in UCa recurrences and to evaluate disease-free survival (DFS) and overall survival (OS) according to CK5/6 and GATA3 expression. Methods: A retr...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
8 Citations
6,184 Views
16 Pages

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening

  • Luis Córdova-Bahena,
  • Axel A. Sánchez-Álvarez,
  • Angel J. Ruiz-Moreno and
  • Marco A. Velasco-Velázquez

22 December 2021

CK1ε is a key regulator of WNT/β-catenin and other pathways that are linked to tumor progression; thus, CK1ε is considered a target for the development of antineoplastic therapies. In this study, we performed a virtual screening...

(This article belongs to the Special Issue Computational Methods in the Design of Anticancer Drugs)
  • Article
  • Open Access
22 Citations
7,412 Views
13 Pages

The Phosphorylation of PDX-1 by Protein Kinase CK2 Is Crucial for Its Stability

  • Sabrina Klein,
  • Rui Meng,
  • Mathias Montenarh and
  • Claudia Götz

28 December 2016

The homeodomain protein PDX-1 is a critical regulator of pancreatic development and insulin production in pancreatic β-cells. We have recently shown that PDX-1 is a substrate of protein kinase CK2; a multifunctional protein kinase which is implicated...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Review
  • Open Access
11 Citations
7,391 Views
26 Pages

CK2 Inhibitors Targeting Inside and Outside the Catalytic Box

  • Sophie Day-Riley,
  • Rebekah M. West,
  • Paul D. Brear,
  • Marko Hyvönen and
  • David R. Spring

CK2 is a protein kinase that plays an important role in numerous cellular pathways involved in cell growth, differentiation, proliferation, and death. Consequently, upregulation of CK2 is implicated in many disease types, in particular cancer. As suc...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research)
  • Review
  • Open Access
86 Citations
10,623 Views
19 Pages

Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks

  • Teresa Nuñez de Villavicencio-Diaz,
  • Adam J. Rabalski and
  • David W. Litchfield

Protein kinase CK2 is a small family of protein kinases that has been implicated in an expanding array of biological processes. While it is widely accepted that CK2 is a regulatory participant in a multitude of fundamental cellular processes, CK2 is...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Review
  • Open Access
149 Citations
13,470 Views
30 Pages

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

  • Melissa M.J. Chua,
  • Charina E. Ortega,
  • Ayesha Sheikh,
  • Migi Lee and ,
  • Hussein Abdul-Rassoul,
  • Kevan L. Hartshorn and
  • Isabel Dominguez
  • + 2 authors+ 0 author

28 January 2017

CK2 genes are overexpressed in many human cancers, and most often overexpression is associated with worse prognosis. Site-specific expression in mice leads to cancer development (e.g., breast, lymphoma) indicating the oncogenic nature of CK2. CK2 is...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Article
  • Open Access
15 Citations
7,936 Views
16 Pages

The Role of Deoxycytidine Kinase (dCK) in Radiation-Induced Cell Death

  • Rui Zhong,
  • Rui Xin,
  • Zongyan Chen,
  • Nan Liang and ,
  • Yang Liu,
  • Shumei Ma and
  • Xiaodong Liu
  • + 2 authors+ 0 author

21 November 2016

Deoxycytidine kinase (dCK) is a key enzyme in deoxyribonucleoside salvage and the anti-tumor activity for many nucleoside analogs. dCK is activated in response to ionizing radiation (IR)-induced DNA damage and it is phosphorylated on Serine 74 by the...

(This article belongs to the Collection Programmed Cell Death and Apoptosis)
  • Article
  • Open Access
11 Citations
2,855 Views
15 Pages

Protective Effect of Ginsenoside CK against Autoimmune Hepatitis Induced by Concanavalin A

  • Jingjing Zhang,
  • Yao Liu,
  • Chao An,
  • Chen Liu and ,
  • Saijian Ma,
  • Qiwen Zhang,
  • Hao Ding,
  • Jingjing Shao and
  • Wenjiao Xue
  • + 4 authors+ 0 author

5 December 2023

Ginsenoside CK, a kind of rare ginsenoside transformed from protopanaxadiol saponins extracted from the genus Panax, has been proven to possess favorable bioactivities such as anti-inflammatory, anti-cancer, anti-diabetes, and hepatoprotective effect...

(This article belongs to the Section Food Nutrition)
  • Article
  • Open Access
1,097 Views
22 Pages

Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines

  • Anne S. Boewe,
  • Hendrik Rumler,
  • Dagmar Aichele,
  • Thomas Bödeker and ,
  • Matthias W. Laschke,
  • Emmanuel Ampofo,
  • Joachim Jose and
  • Claudia Götz
  • + 3 authors+ 0 author

Glioblastoma is one of the most aggressive tumours with a poor prognosis and a modest survival rate after diagnosis. Several trials for a more targeted and effective treatment are in progress. Protein kinase CK2 is upregulated in glioblastoma and cre...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
2 Citations
2,489 Views
17 Pages

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders

  • Beatrice Francucci,
  • Simone Angeloni,
  • Diego Dal Ben,
  • Catia Lambertucci and ,
  • Massimo Ricciutelli,
  • Andrea Spinaci,
  • Aleksei Smirnov,
  • Rosaria Volpini,
  • Michela Buccioni and
  • Gabriella Marucci
  • + 5 authors+ 0 author

14 June 2023

Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several factors contribute to their development, including overexpression of A2A adenosine receptors...

(This article belongs to the Special Issue Design, Synthesis and Biological Evaluation of Novel Small Molecules Inhibitors)
  • Article
  • Open Access
18 Citations
7,568 Views
15 Pages

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

  • Benoît Bestgen,
  • Zakia Belaid-Choucair,
  • Thierry Lomberget,
  • Marc Le Borgne and ,
  • Odile Filhol and
  • Claude Cochet
  • + 1 author+ 0 author

3 February 2017

Protein kinase CK2 is a tetrameric holoenzyme composed of two catalytic (α and/or α’) subunits and two regulatory (β) subunits. Crystallographic data paired with fluorescence imaging techniques have suggested that the formation of the CK2 holoenzyme...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Article
  • Open Access
2,016 Views
30 Pages

Protein kinase CK2 is an important regulator of cell, embryo, and organism function whose transcript levels are often dysregulated in disease. Previous studies have primarily focused on the regulation of CK2 gene expression via the proximal promoter....

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research—2nd Edition)
  • Article
  • Open Access
12 Citations
4,282 Views
16 Pages

Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells

  • Francesca Zonta,
  • Christian Borgo,
  • Camila Paz Quezada Meza,
  • Ionica Masgras and ,
  • Andrea Rasola,
  • Mauro Salvi,
  • Lorenzo A. Pinna and
  • Maria Ruzzene
  • + 3 authors+ 0 author

18 January 2021

CK2 is a Ser/Thr protein kinase overexpressed in many cancers. It is usually present in cells as a tetrameric enzyme, composed of two catalytic (α or α’) and two regulatory (β) subunits, but it is active also in its monomeric f...

(This article belongs to the Special Issue Metabolic Rewiring in Cancer Cells: From Tumor Onset to Novel Therapies)
  • Article
  • Open Access
2 Citations
2,085 Views
27 Pages

Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs)

  • Malte Arnold,
  • Temi Thompson,
  • Lorraine Glennie,
  • Mattes Hollnagel and ,
  • Gopal Sapkota and
  • Christian Peifer
  • + 1 author+ 0 author

18 November 2025

The dysregulation of CK1 isoforms is linked to various types of diseases, including neurodegeneration and different types of neoplasia such as colon, pancreatic, breast, and ovarian cancer. For CK1 isoforms, a plethora of effective small molecule inh...

  • Review
  • Open Access
58 Citations
15,683 Views
23 Pages

20 February 2017

Casein kinase II (CK2) is an ubiquitous and pleiotropic serine/threonine protein kinase able to phosphorylate hundreds of substrates. Being implicated in several human diseases, from neurodegeneration to cancer, the biological roles of CK2 have been...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Article
  • Open Access
2,261 Views
29 Pages

Structure–Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2

  • Lukas Kröger,
  • Sebastian Borgert,
  • Miriam Lauwers,
  • Michaela Steinkrüger and ,
  • Joachim Jose,
  • Markus Pietsch and
  • Bernhard Wünsch
  • + 2 authors+ 0 author

27 December 2024

The serine/threonine kinase CK2 (formerly known as casein kinase II) plays a crucial role in various CNS disorders and is highly expressed in various types of cancer. Therefore, inhibiting this key kinase could be promising for the treatment of these...

(This article belongs to the Special Issue Heterocycles in Medicinal Chemistry III)
  • Review
  • Open Access
19 Citations
6,345 Views
10 Pages

Protein kinase CK2 is a Ser/Thr protein kinase that phosphorylates hundreds of substrates mainly related to survival and proliferation pathways. It has long been considered an anti-cancer drug target. However, during the recent COVID-19 pandemic, CK2...

(This article belongs to the Special Issue Past, Present and Future of Protein Kinase CK2 Research)
  • Review
  • Open Access
7 Citations
6,613 Views
8 Pages

7 February 2017

The atypical kinase Rio1 is widespread in many organisms, ranging from Archaebacteria to humans, and is an essential factor in ribosome biogenesis. Little is known about the protein substrates of the enzyme and small-molecule inhibitors of the kinase...

(This article belongs to the Special Issue An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2)
  • Review
  • Open Access
11 Citations
3,999 Views
22 Pages

In gliomas, casein kinase 2 (CK2) plays a dominant role in cell survival and tumour invasiveness and is upregulated in many brain tumours. Among CK2 inhibitors, benzimidazole and isothiourea derivatives hold a dominant position. While targeting gliom...

(This article belongs to the Special Issue Protein Kinase Inhibitors for Targeted Anticancer Therapies)
  • Article
  • Open Access
6 Citations
4,390 Views
13 Pages

Osteoporosis is a bone disease that has no definite cure. Current treatments for osteoporosis are divided into two categories: anti-resorptive and anabolic. However, these treatments are not perfect and have considerable risks. In addition, bone qual...

(This article belongs to the Special Issue Osteoporosis: From Molecular Mechanisms to Therapies 2.0)

of 97